Munshi Amit
SEC-identified person · CIK 1612551 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Inhibikase Therapeutics, Inc. IKT | Director | filed 2024 - 2026 |
| Zura Bio Ltd ZURA | Director | filed 2023 - 2026 |
| Arcutis Biotherapeutics, Inc. ARQT | Director | filed 2025 - 2026 |
| Galecto, Inc. GLTO | Director | filed 2020 - 2025 |
| Arena Pharmaceuticals INC ARNA | Director · President and CEO | filed 2016 - 2022 |
| Social Capital Suvretta Holdings Corp. IV DNAD | Director | filed 2021 - 2021 |
| Ruthigen, Inc. RTGN | Director | filed 2017 - 2021 |
| Zalicus Inc. ZLCS | Director · Chief Executive Officer | filed 2014 - 2016 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.